Global monopoly of technology

"Mr. Lu, not only Borch Technology is supported by Luo Sheng, another medical equipment provider that is also highly anticipated today also has Luo Sheng's capital background in Huachang Technology."

"What are you talking about? Fuck it!"

The VC manager surnamed Lu heard what the secretary said, and for a while, he couldn't help but explode.

This news is both good news and bad news for other venture capital institutions. The good news is that Luo Sheng is optimistic that it has a bright future. The bad news is that it is difficult to get a share of the pie.

With the emergence of the show at the Medical Expo, the attention of these two newly established technology companies has rapidly increased, especially Borch Technology, and the information of Chen Xinhe's company has also been further exposed soon.

It doesn't need to be too troublesome. You can find some key information by opening the "Sky Eye Check" app on your mobile phone. The reason for not causing such a big movement before is because of insufficient attention, no big news, and lack of breaking points.

One piece of information is undoubtedly attracting attention, that is, Luo Sheng's name is impressive, and he is an angel investor in these two technology companies, and he invested in his personal name.

Outsiders have an inexplicable feeling, no wonder it is so beautiful, it turns out to be supported by Luo Sheng.

In today's science and technology world, the name "Luo Sheng" has unparalleled magic power. As long as the startups or entrepreneurs favored by this name or the organization behind this name can quickly become the darling of capital sought after.

...

"I'm sorry, Huachang Technology currently has no financing plan, and has an agreement with Mr. Luo to only accept Mr. Luo's exclusive investment unless he voluntarily gives up financing or he agrees to a third-party venture capital institution to come in."

"Sorry, Manager Lu, Bochuang Technology currently has no plans to raise external funds..."

About half an hour later, the major VCs who heard the wind went to the booth and met with Chen Xin and Chao Junhui respectively, with the purpose and directness, and wanted to invest in their companies.

But they were rejected without exception, which made the people of the major venture capital institutions very uncomfortable. If it is an ordinary entrepreneur or a startup company, this is shameless. There are ways and means to make them succumb to the pressure of capital. under.

But these two can't work. There is Luo Sheng's name for it. No one dares to do that. In terms of capital strength, there is currently no venture capital institution in the world that can beat Luo Sheng in capital strength.

This result makes many VC agencies feel like they want to cry without tears. Suddenly they are overjoyed when they find the baby, seemingly at their fingertips, but find that it has nothing to do with them.

Don't mention too much trouble.

Why do these promising start-ups have Luo Sheng's shadow?This makes many VC institutions feel extremely unhappy, but also have to admire, as the legend of the first person in the contemporary science and technology circle is indeed well-deserved.

After turning down the VC person who came to talk with him, Chen Xin's assistant came over with an iP tablet and handed it to him.

"Mr. Chen, Mr. Luo has sent you two emails."

Chen Xin took the tablet, clicked on the list of unread emails, and passed it back to his assistant in no time. Without thinking about it, he directly ordered: "Just follow the above and do it as soon as possible. The sooner the better."

"Mr. Chen, but Mr. Luo didn't pay us. These equipments are very expensive, and some of them have to be purchased in Europe."

Hearing that, Chen Xin wanted to reprimand his assistant, but held back, and said: "Then use the company's book liquidity to do it first. Are you still worried that the old man will cheat me on this money? Those who want to do things for the boss If there is no one thousand and no less than eight hundred, he trusted and respected me by entrusting this matter to me, and he knew what to do?"

Don't think that Chen Xin is a carefree and somewhat anti-authoritative young post-90s, but he is also a master who knows how to come and is very sensible. He is clever and has high double quotients.

And his assistant was not Yumu's head. He suddenly realized this and nodded: "I understand, I will deal with it myself immediately."

With Chen Xin's words, his assistant quickly heard a pun, and now this matter is left to himself, and it is also his trust and respect.

If you can't even realize this, then don't even think about climbing up.

On the other hand, Cao Junhui also received the news, and did not neglect this matter, and immediately arranged this matter. The golden master's father had to take care of him, not neglect, it was just a matter of running errands.

Moreover, this is not a normal errand. There are intangible benefits in it. This shows that the relationship with Luo Sheng is different than that of other founders.

The relationship is very strange. Everyone in the business community is a human being, and they can judge a lot of valuable information from some seemingly inadvertent little things.

In this realistic society, most of the time you do something is done by people.

As Huachang Technology and Bochuang Technology became famous on the first day of the Medical Expo, they quickly spread in the industry. In addition to the excellent product itself, especially the blessing of the exposure of Luo Sheng’s magical aura, this name Once again, the influence of has been perfectly interpreted.

Suddenly, two new-faced companies became the biggest winners of the medical expo, fame, fame, fame, fame, fame, fame, fame, fame, and fame, can the profit be far behind?

Sure enough, what followed was that customer orders were already on their way. In the afternoon, 10 hospitals and distributors with medical device business licenses came to Borch Technology to place orders, and they directly placed 50,000 orders in one go. An arm or leg prosthesis order, this order is 2.25 billion yuan.

However, what is interesting is that Chen Xin has a special additional clause in the contract, that is, the partner can only earn a maximum of 15% of the profit. If the profit exceeds the profit, the cooperation will be terminated. His original dream of establishing Borch Technology to research bionic prosthetics was to give Amputees provide cheap products.

At present, although Borch Technology can supply the market with medical equipment operating qualifications, its production capacity has not been improved, and its own sales channel network has not been established.

This order has already covered the company's production capacity this year. According to this trend, the market phenomenon of this product will be in short supply.

After all, the price is 10 times lower than that of other prosthetic products on the market, and at the same time the performance is spiked. One can imagine how strong this competitiveness is.

Due to insufficient supply, the price will inevitably be raised by the market, and the price difference will be earned by the middlemen. This obviously violates Chen Xin’s original intention of starting a business. His short-term response strategy is also simple and rude. Whoever raises the price will not give him Available.

This waywardness is because so far, Borch Technology's unparalleled competitiveness, only his family can supply the market.

However, Chen Xin also knows that it is impossible to fundamentally prevent the product from being speculated and make a large profit by the middle, because this violates the basic logic of economic activities that are scarce.

There is always a way for middlemen to increase profits.

If you really want to lower the price, only increasing the production capacity is the fundamental solution to the problem. In addition, you have to establish your own sales channel network. Chen Xin decided to learn from the marketing model of the Côte d'Azur offline stores.

When the production capacity is increased and the sales channels are established, the prices will naturally come down.

Huachang Technology is also a great harvest. On the same day, 42 major domestic and foreign pharmaceutical companies came to order to purchase its "organ simulator" equipment, which can even be said to be scrambling.

This set of equipment has great benefits and significance for the research and development of biopharmaceuticals. Prior to this, there has not been any equipment that can simulate the entire cycle of human metabolism before the drug enters the clinical stage. It can only be tested with mice.

Obviously, guinea pigs are not rigorous enough, and using volunteers will bring great risks.

But with this set of equipment to assist the development of new drugs, the cost and cost of trial and error are greatly reduced, the risk of clinical trials is greatly reduced, and the efficiency of research and development is improved, because large-scale experiments can be carried out with confidence, and the efficiency of new drug research and development is of course It will improve.

This set of equipment is not cheap. The price of a single set is as high as 12.2 million US dollars. However, after learning about this medical device, domestic and foreign pharmaceutical companies are still rushing to grab the order. The reason is that a slow step may delay the development of their own pharmaceutical companies. And since Huachang Technology was established not long ago, the production capacity is definitely not for a while, so it will have to grab orders.

Although it is not cheap, it is a trivial matter to these large pharmaceutical companies. Large international pharmaceutical companies such as Roche and Novartis spend tens of billions of dollars in research and development each year.

Huachang Technology signed a total of 105 sets of purchase order contracts on the same day, with a total value of US$1.28 billion. It became the biggest winner of this medical expo, which exceeded everyone's expectations.

The VC institutions that want to invest are now giving up. They have already begun to make a big profit. Don't think about financing or anything.

The 42 pharmaceutical companies purchased this time are all famous in the world. Dozens of major international pharmaceutical companies such as Roche, Novartis, Pfizer, Johnson & Johnson have become Huachang Technology customers.

It is worth mentioning that from the dozens of pharmaceutical companies that have placed orders, it can be seen that the strength of domestic pharmaceutical companies is still much behind. In the customer list of purchase orders, all the top 30 global pharmaceutical companies are listed, while domestic pharmaceutical companies None of the companies are on this list.

There is no doubt that the level of biopharmaceuticals is one of the important indicators to measure the comprehensive national strength of a country. It is an important area related to the national economy and people's livelihood, especially the outbreak of public health emergencies, which is of irreplaceable importance.

This year, according to the latest ranking of global pharmaceutical companies published by the North American "Pharmaceutical Manager" magazine, the top ten pharmaceutical companies are in North America and 5 companies, 2 in Switzerland, 1 in France, and 1 in Japan.

There are only four top-ranked pharmaceutical companies in China, which are also ranked 37th, 42nd, 43rd and 48th in the global pharmaceutical company rankings.

In the field of medical technology, obviously there is still a long way to go, and this time Huachang Technology shines, attracting the top 30 global pharmaceutical companies to come to the world, and it can be said that the order to purchase its medical equipment is both. Earning a lot of money for myself and saving face for this medical expo undoubtedly greatly encouraged the development of the domestic medical industry.

Although the domestic pharmaceutical companies are not as good as the top 30 in the world, Huachang Technology gives priority to several domestic pharmaceutical companies, and the number of equipment is four sets. On the contrary, the large international pharmaceutical companies that are not bad are not only lining up behind. Moreover, one family currently only supplies two sets, so price increase and volume increase will not work.

The major international pharmaceutical companies are very dissatisfied with this, but they can only bear it. Who makes Huachang Technology the only equipment provider in the world that can produce a complete set of human metabolic cycle simulations?

The significance of this product to the development of clinical medicine is clear to pharmaceutical companies engaged in the biopharmaceutical field.

...